From access and reimbursement to webinars and useful links, our Billing Professionals Resource Center has the tools to help you stay informed.
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide for Aranesp®.
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide for BLINCYTO®.
Please see Full Prescribing Information, including Boxed WARNINGS, for KANJINTI®.
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide for RIABNI™.
Please see Full Prescribing Information, including Boxed WARNINGS, for Vectibix®.
The following documents are available for download:
Make a one-time call to the Register Terminal
For patients prescribed an eligible Amgen product, identify patients prior to treatment initiation
Eligibility requirements and a list of brands covered by the Amgen FIRST STEP™ program are available at AmgenFIRSTSTEP.com.
Assist patients with registration by having them fill out required forms, available at AmgenFIRSTSTEP.com:
Enrollment form with eligibility questions
Privacy Notice and Patient Authorization form
Register patient before any treatment.
Swipe patient's card to collect deductible, co-insurance, or co-payment for one dose of the Amgen product
First swipe: patient OOP cost share = $0
Subsequent swipe: Patient share = $5 (except for Prolia® (denosumab), which is $25)
To submit Explanation of Benefits (EOB) and other relevant documentation, please fax 1-866-653-2972 or mail to: ConnectiveRx at 100 Passaic Avenue, Suite 245, Fairfield, NJ 07004 - ATTN: Amgen FIRST STEP™ Program. Submit EOB within 45 days of initial swipe.
Make a one-time call to the Register Terminal
Amgen Reimbursement Counselors can assist with submitting, storing, and retrieving benefit verifications for anyone currently on an Amgen product.
Visit the Benefit CenterConnect today with an Amgen Reimbursement Counselor, or schedule a visit with a Field Reimbursement Specialist.
Find a Specialist* Terms, conditions, and program maximums apply. This program is not open to patients receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program. Not valid where prohibited by law.
†$25 out-of-pocket cost for subsequent dose or cycle of Prolia® (denosumab); $5 out-of-pocket cost for subsequent dose or cycle of other products through Amgen FIRST STEP™.